DRB18 (0-10 μM; 30 min) reduces glucose uptake in GLUT1-4-expressed HEK293 cell lines in a dose-dependent manner with IC50s varying from ~ 900 nM to ~ 9 μM.DRB18 (5 and 10 μM; 72 hours) causes cell cycle arrest in the G1/S phase transition.DRB18 (5 and 10 μM; 72 hours) increases ROS levels in A549 cells.DRB18 (5 and 10 μM; 72 hours) reduces expression of glycosylated GLUT1 and GLUT2-4 in A549 cells in a dose-dependent manner. has not independently confirmed the accuracy of these methods. They are for reference only.
DRB18 (10 mg/kg; IP; thrice a week for 5 weeks) inhibits tumors volume by 44% and tumors weight by 43%. has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: Male NU/J nude mice (3-4 weeks;